These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30091600)

  • 41. Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.
    Balakrishnan K; Fu M; Onida F; Wierda WG; Keating MJ; Gandhi V
    Oncotarget; 2016 Jun; 7(26):39458-39472. PubMed ID: 27223062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Dynamics simulations of Inhibitor of Apoptosis Proteins and identification of potential small molecule inhibitors.
    Jayakumar J; Anishetty S
    Bioorg Med Chem Lett; 2014 May; 24(9):2098-104. PubMed ID: 24717152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Learning and confirming with preclinical studies: modeling and simulation in the discovery of GDC-0917, an inhibitor of apoptosis proteins antagonist.
    Wong H; Gould SE; Budha N; Darbonne WC; Kadel EE; La H; Alicke B; Halladay JS; Erickson R; Portera C; Tolcher AW; Infante JR; Mamounas M; Flygare JA; Hop CE; Fairbrother WJ
    Drug Metab Dispos; 2013 Dec; 41(12):2104-13. PubMed ID: 24041744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IAP family of cell death and signaling regulators.
    Silke J; Vucic D
    Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitor.
    Ruel R; Thibeault C; L'Heureux A; Martel A; Cai ZW; Wei D; Qian L; Barrish JC; Mathur A; D'Arienzo C; Hunt JT; Kamath A; Marathe P; Zhang Y; Derbin G; Wautlet B; Mortillo S; Jeyaseelan R; Henley B; Tejwani R; Bhide RS; Trainor GL; Fargnoli J; Lombardo LJ
    Bioorg Med Chem Lett; 2008 May; 18(9):2985-9. PubMed ID: 18395443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway.
    Pang Y; Si M; Sun B; Niu L; Xu X; Lu T; Yuan H; Lou H
    Food Chem Toxicol; 2014 Jul; 69():163-74. PubMed ID: 24751974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitor of apoptosis proteins as novel targets in inflammatory processes.
    Mayer BA; Rehberg M; Erhardt A; Wolf A; Reichel CA; Kracht M; Krombach F; Tiegs G; Zahler S; Vollmar AM; Fürst R
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2240-50. PubMed ID: 21817100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.
    Hashimoto K; Saito B; Miyamoto N; Oguro Y; Tomita D; Shiokawa Z; Asano M; Kakei H; Taya N; Kawasaki M; Sumi H; Yabuki M; Iwai K; Yoshida S; Yoshimatsu M; Aoyama K; Kosugi Y; Kojima T; Morishita N; Dougan DR; Snell GP; Imamura S; Ishikawa T
    J Med Chem; 2013 Feb; 56(3):1228-46. PubMed ID: 23298277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.
    Hikami S; Shiozaki A; Kitagawa-Juge M; Ichikawa D; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E
    Dig Dis Sci; 2017 Mar; 62(3):652-659. PubMed ID: 28050781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase.
    Gingrich DE; Lisko JG; Curry MA; Cheng M; Quail M; Lu L; Wan W; Albom MS; Angeles TS; Aimone LD; Haltiwanger RC; Wells-Knecht K; Ott GR; Ghose AK; Ator MA; Ruggeri B; Dorsey BD
    J Med Chem; 2012 May; 55(10):4580-93. PubMed ID: 22564207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer.
    Ye W; Gunti S; Allen CT; Hong Y; Clavijo PE; Van Waes C; Schmitt NC
    Oncoimmunology; 2020; 9(1):1710398. PubMed ID: 32002309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rigidity versus Flexibility: Is This an Issue in σ1 Receptor Ligand Affinity and Activity?
    Weber F; Brune S; Börgel F; Lange C; Korpis K; Bednarski PJ; Laurini E; Fermeglia M; Pricl S; Schepmann D; Wünsch B
    J Med Chem; 2016 Jun; 59(11):5505-19. PubMed ID: 27156565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
    Pinard E; Alanine A; Alberati D; Bender M; Borroni E; Bourdeaux P; Brom V; Burner S; Fischer H; Hainzl D; Halm R; Hauser N; Jolidon S; Lengyel J; Marty HP; Meyer T; Moreau JL; Mory R; Narquizian R; Nettekoven M; Norcross RD; Puellmann B; Schmid P; Schmitt S; Stalder H; Wermuth R; Wettstein JG; Zimmerli D
    J Med Chem; 2010 Jun; 53(12):4603-14. PubMed ID: 20491477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein.
    Opo FADM; Rahman MM; Ahammad F; Ahmed I; Bhuiyan MA; Asiri AM
    Sci Rep; 2021 Feb; 11(1):4049. PubMed ID: 33603068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
    Mallams AK; Rossman RR; Doll RJ; Girijavallabhan VM; Ganguly AK; Petrin J; Wang L; Patton R; Bishop WR; Carr DM; Kirschmeier P; Catino JJ; Bryant MS; Chen KJ; Korfmacher WA; Nardo C; Wang S; Nomeir AA; Lin CC; Li Z; Chen J; Lee S; Dell J; Lipari P; Liu M
    J Med Chem; 1998 Mar; 41(6):877-93. PubMed ID: 9526562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of diarylthiazole B-raf inhibitors: identification of a compound endowed with high oral antitumor activity, mitigated hERG inhibition, and low paradoxical effect.
    Pulici M; Traquandi G; Marchionni C; Modugno M; Lupi R; Amboldi N; Casale E; Colombo N; Corti L; Fasolini M; Gasparri F; Pastori W; Scolaro A; Donati D; Felder E; Galvani A; Isacchi A; Pesenti E; Ciomei M
    ChemMedChem; 2015 Feb; 10(2):276-95. PubMed ID: 25430902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.
    Cai Q; Sun H; Peng Y; Lu J; Nikolovska-Coleska Z; McEachern D; Liu L; Qiu S; Yang CY; Miller R; Yi H; Zhang T; Sun D; Kang S; Guo M; Leopold L; Yang D; Wang S
    J Med Chem; 2011 Apr; 54(8):2714-26. PubMed ID: 21443232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting XIAP for the treatment of malignancy.
    Schimmer AD; Dalili S; Batey RA; Riedl SJ
    Cell Death Differ; 2006 Feb; 13(2):179-88. PubMed ID: 16322751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Silico Designing and Screening of Antagonists against Cancer Drug Target XIAP.
    Kumar R; Chauhan JS; Raghava GP
    Curr Cancer Drug Targets; 2015; 15(9):836-46. PubMed ID: 26143944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imatinib mesylate.
    Al-Hadiya BM; Bakheit AH; Abd-Elgalil AA
    Profiles Drug Subst Excip Relat Methodol; 2014; 39():265-97. PubMed ID: 24794909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.